Orbimed Advisors as of June 30, 2023
Portfolio Holdings for Orbimed Advisors
Orbimed Advisors holds 121 positions in its portfolio as reported in the June 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Sinovac Biotech SHS | 6.1 | $340M | 2.7M | 125.06 | |
| Intuitive Surgical Com New (ISRG) | 3.8 | $212M | 621k | 341.94 | |
| Enliven Therapeutics (ELVN) | 3.3 | $184M | 9.0M | 20.41 | |
| Boston Scientific Corporation (BSX) | 3.3 | $183M | 3.4M | 54.09 | |
| Baxter International Call Option (BAX) | 3.0 | $167M | 3.7M | 45.56 | |
| Humana (HUM) | 3.0 | $167M | 374k | 447.13 | |
| Theseus Pharmaceuticals | 2.9 | $161M | 17M | 9.33 | |
| Biogen Idec (BIIB) | 2.9 | $159M | 557k | 284.85 | |
| BioMarin Pharmaceutical (BMRN) | 2.5 | $140M | 1.6M | 86.68 | |
| UnitedHealth (UNH) | 2.1 | $117M | 244k | 480.64 | |
| Edgewise Therapeutics (EWTX) | 2.0 | $113M | 15M | 7.75 | |
| Acelyrin | 2.0 | $111M | 5.3M | 20.90 | |
| Springworks Therapeutics (SWTX) | 2.0 | $110M | 4.2M | 26.22 | |
| Disc Medicine (IRON) | 1.8 | $101M | 2.3M | 44.40 | |
| Bristol Myers Squibb (BMY) | 1.7 | $95M | 1.5M | 63.95 | |
| Ionis Pharmaceuticals (IONS) | 1.6 | $89M | 2.2M | 41.03 | |
| United Therapeutics Corporation (UTHR) | 1.6 | $89M | 402k | 220.75 | |
| Evolent Health Cl A (EVH) | 1.6 | $88M | 2.9M | 30.30 | |
| Vectivbio Hldg Ord Shs | 1.6 | $88M | 5.2M | 17.00 | |
| Eli Lilly & Co. (LLY) | 1.6 | $87M | 186k | 468.98 | |
| Tenet Healthcare Corp Com New (THC) | 1.6 | $86M | 1.1M | 81.38 | |
| Thermo Fisher Scientific (TMO) | 1.5 | $85M | 163k | 521.75 | |
| Apellis Pharmaceuticals (APLS) | 1.5 | $83M | 910k | 91.10 | |
| Stryker Corporation (SYK) | 1.5 | $83M | 271k | 305.09 | |
| Verona Pharma Sponsored Ads (VRNA) | 1.4 | $80M | 3.8M | 21.14 | |
| Ikena Oncology Nonvoting | 1.4 | $78M | 12M | 6.56 | |
| Sarepta Therapeutics (SRPT) | 1.4 | $75M | 654k | 114.52 | |
| Madrigal Pharmaceuticals (MDGL) | 1.3 | $74M | 322k | 231.00 | |
| Crinetics Pharmaceuticals In (CRNX) | 1.3 | $71M | 4.0M | 18.02 | |
| Compass Therapeutics (CMPX) | 1.3 | $71M | 22M | 3.18 | |
| Xtant Med Hldgs Com New (XTNT) | 1.2 | $68M | 73M | 0.93 | |
| Terns Pharmaceuticals (TERN) | 1.2 | $67M | 7.6M | 8.75 | |
| R1 RCM (RCM) | 1.1 | $64M | 3.4M | 18.45 | |
| Si-bone (SIBN) | 1.1 | $62M | 2.3M | 26.98 | |
| Keros Therapeutics (KROS) | 1.1 | $61M | 1.5M | 40.18 | |
| Silverback Therapeutics (SPRY) | 1.1 | $59M | 8.7M | 6.70 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 1.1 | $58M | 165k | 351.91 | |
| Scpharmaceuticals (SCPH) | 1.0 | $57M | 5.6M | 10.19 | |
| Syndax Pharmaceuticals (SNDX) | 1.0 | $53M | 2.5M | 20.93 | |
| Vaxcyte (PCVX) | 0.9 | $50M | 1.0M | 49.94 | |
| Prelude Therapeutics (PRLD) | 0.9 | $49M | 11M | 4.50 | |
| Edwards Lifesciences (EW) | 0.9 | $49M | 515k | 94.33 | |
| Natera (NTRA) | 0.9 | $47M | 974k | 48.66 | |
| Neurocrine Biosciences (NBIX) | 0.8 | $46M | 489k | 94.30 | |
| Cigna Corp (CI) | 0.8 | $45M | 161k | 280.60 | |
| Xenon Pharmaceuticals (XENE) | 0.8 | $42M | 1.1M | 38.50 | |
| Alpine Immune Sciences | 0.8 | $42M | 4.1M | 10.28 | |
| Pmv Pharmaceuticals (PMVP) | 0.7 | $41M | 6.6M | 6.26 | |
| Horizon Therapeutics Pub L SHS | 0.7 | $38M | 366k | 102.85 | |
| Zimmer Holdings (ZBH) | 0.6 | $36M | 245k | 145.60 | |
| Repare Therapeutics Ord (RPTX) | 0.6 | $35M | 3.3M | 10.58 | |
| Gracell Biotechnologies Sponsored Ads | 0.6 | $34M | 9.0M | 3.81 | |
| Janux Therapeutics (JANX) | 0.6 | $34M | 2.8M | 11.87 | |
| Iovance Biotherapeutics (IOVA) | 0.6 | $33M | 4.7M | 7.04 | |
| Mirati Therapeutics | 0.6 | $33M | 914k | 36.13 | |
| Travere Therapeutics (TVTX) | 0.6 | $33M | 2.1M | 15.36 | |
| Tela Bio (TELA) | 0.5 | $29M | 2.8M | 10.13 | |
| Amgen (AMGN) | 0.5 | $28M | 127k | 222.02 | |
| Vera Therapeutics Cl A (VERA) | 0.5 | $28M | 1.8M | 16.05 | |
| Third Harmonic Bio (THRD) | 0.5 | $28M | 5.8M | 4.81 | |
| Abcellera Biologics (ABCL) | 0.5 | $27M | 4.2M | 6.46 | |
| Mersana Therapeutics Call Option | 0.4 | $25M | 7.5M | 3.29 | |
| Kinnate Biopharma | 0.4 | $24M | 8.0M | 3.03 | |
| 2seventy Bio Common Stock | 0.4 | $24M | 2.4M | 10.12 | |
| Uniqure Nv SHS (QURE) | 0.4 | $24M | 2.1M | 11.46 | |
| Rapt Therapeutics | 0.4 | $23M | 1.3M | 18.70 | |
| Amicus Therapeutics (FOLD) | 0.4 | $23M | 1.9M | 12.56 | |
| Alx Oncology Hldgs (ALXO) | 0.4 | $22M | 2.9M | 7.51 | |
| Ikena Oncology (IKNA) | 0.4 | $21M | 3.2M | 6.56 | |
| Adicet Bio (ACET) | 0.4 | $20M | 8.3M | 2.43 | |
| Decibel Therapeutics | 0.3 | $19M | 4.9M | 3.85 | |
| Arcutis Biotherapeutics (ARQT) | 0.3 | $18M | 1.9M | 9.53 | |
| Neuropace (NPCE) | 0.3 | $18M | 4.0M | 4.49 | |
| Ventyx Biosciences (VTYX) | 0.3 | $18M | 541k | 32.80 | |
| Corvus Pharmaceuticals (CRVS) | 0.3 | $16M | 6.9M | 2.29 | |
| Fusion Pharmaceuticals | 0.3 | $15M | 3.1M | 4.67 | |
| X4 Pharmaceuticals | 0.3 | $14M | 7.1M | 1.94 | |
| Kezar Life Sciences | 0.2 | $13M | 5.5M | 2.45 | |
| Aerovate Therapeutics (AVTE) | 0.2 | $13M | 757k | 17.15 | |
| Argenx Se Sponsored Adr (ARGX) | 0.2 | $13M | 33k | 389.73 | |
| Morphic Hldg (MORF) | 0.2 | $12M | 209k | 57.33 | |
| Verastem Com New (VSTM) | 0.2 | $11M | 1.5M | 7.44 | |
| Immatics SHS (IMTX) | 0.2 | $11M | 967k | 11.54 | |
| Goodrx Hldgs Com Cl A (GDRX) | 0.2 | $9.9M | 1.8M | 5.52 | |
| Regeneron Pharmaceuticals (REGN) | 0.2 | $9.7M | 14k | 718.54 | |
| Galecto | 0.2 | $9.7M | 3.8M | 2.52 | |
| Passage Bio | 0.2 | $9.5M | 10M | 0.94 | |
| Akero Therapeutics (AKRO) | 0.2 | $9.3M | 200k | 46.69 | |
| Bridgebio Pharma Note 2.250% 2/0 (Principal) | 0.2 | $9.3M | 15M | 0.62 | |
| Oric Pharmaceuticals (ORIC) | 0.2 | $9.1M | 1.2M | 7.76 | |
| Gh Research Ordinary Shares (GHRS) | 0.2 | $8.7M | 736k | 11.87 | |
| Gilead Sciences (GILD) | 0.1 | $7.7M | 100k | 77.07 | |
| Moonlake Immunotherapeutics Class A Ord (MLTX) | 0.1 | $6.0M | 117k | 51.00 | |
| Ys Biopharma Ordinary Shares | 0.1 | $5.9M | 4.3M | 1.38 | |
| Cullinan Oncology (CGEM) | 0.1 | $5.9M | 545k | 10.76 | |
| Cutera | 0.1 | $5.9M | 387k | 15.13 | |
| Scholar Rock Hldg Corp (SRRK) | 0.1 | $5.5M | 736k | 7.54 | |
| Adagio Therapeutics (IVVD) | 0.1 | $5.5M | 5.3M | 1.05 | |
| Nextcure (NXTC) | 0.1 | $4.9M | 2.7M | 1.80 | |
| Alkermes SHS (ALKS) | 0.1 | $4.7M | 151k | 31.30 | |
| Inspiremd (NSPR) | 0.1 | $4.7M | 1.9M | 2.51 | |
| Vigil Neuroscience (VIGL) | 0.1 | $4.2M | 449k | 9.40 | |
| Arrowhead Pharmaceuticals (ARWR) | 0.1 | $4.2M | 117k | 35.66 | |
| Apollomics Cl A Shs | 0.1 | $3.8M | 663k | 5.73 | |
| Bioatla (BCAB) | 0.1 | $3.5M | 1.2M | 3.00 | |
| Chemomab Therapeutics Sponsored Ads | 0.1 | $2.9M | 2.2M | 1.31 | |
| Synlogic | 0.0 | $2.6M | 6.0M | 0.43 | |
| Revance Therapeutics | 0.0 | $2.5M | 100k | 25.31 | |
| Essa Pharma Com New (EPIX) | 0.0 | $2.5M | 922k | 2.70 | |
| Acutus Medical (AFIB) | 0.0 | $2.4M | 2.6M | 0.89 | |
| Elevation Oncology (ELEV) | 0.0 | $2.3M | 1.5M | 1.52 | |
| Bolt Biotherapeutics | 0.0 | $2.0M | 1.5M | 1.28 | |
| Protara Therapeutics Com Stk (TARA) | 0.0 | $1.8M | 773k | 2.39 | |
| Chardan Healthcare Acqu- Ord | 0.0 | $1.6M | 4.6M | 0.36 | |
| Calcimedica Com New (CALC) | 0.0 | $1.2M | 297k | 4.01 | |
| Tg Therapeutics Call Option (TGTX) | 0.0 | $1.1M | 46k | 24.84 | |
| Heron Therapeutics (HRTX) | 0.0 | $931k | 803k | 1.16 | |
| Singular Genomics Systems In | 0.0 | $449k | 541k | 0.83 | |
| Harpoon Therapeutics | 0.0 | $441k | 621k | 0.71 | |
| Altimmune Com New (ALT) | 0.0 | $353k | 100k | 3.53 | |
| Nektar Therapeutics Call Option | 0.0 | $296k | 515k | 0.58 |
